Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
1(6%)
Results Posted
100%(10 trials)
Terminated
3(18%)

Phase Distribution

Ph phase_1
6
35%
Ph phase_4
3
18%
Ph not_applicable
1
6%
Ph phase_2
4
24%

Phase Distribution

6

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
6(42.9%)
Phase 2Efficacy & side effects
4(28.6%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(3)
Completed(10)
Terminated(3)
Other(1)

Detailed Status

Completed10
Terminated3
Not yet recruiting2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
76.9%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (42.9%)
Phase 24 (28.6%)
Phase 43 (21.4%)
N/A1 (7.1%)

Trials by Status

not_yet_recruiting212%
recruiting16%
terminated318%
completed1059%
unknown16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT04005469Phase 1

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Recruiting
NCT05564637Phase 2

A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

Completed
NCT07177703Phase 2

Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension

Not Yet Recruiting
NCT06603285

A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin

Not Yet Recruiting
NCT00439946Phase 4

Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH

Terminated
NCT01481974Phase 1

Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation

Completed
NCT05067270Phase 1

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Completed
NCT03835676Phase 4

Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension

Unknown
NCT02498444Not Applicable

Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation

Terminated
NCT03888365

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

Completed
NCT04675944Phase 1

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

Completed
NCT00705133Phase 2

Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension

Completed
NCT02769624Phase 2

Acute Effects of Inhaled Treprostinil in Fontan Patients

Terminated
NCT02770521Phase 1

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Completed
NCT01268553Phase 4

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

Completed
NCT01028651

A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension

Completed
NCT01082484Phase 1

Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17